Real-time enrollment status for this solid tumors clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:17 AM UTC
| NCT Number | NCT06077877 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 135 participants |
| Active Locations | 6 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | February 2, 2026 (4 weeks ago) |
As of March 2, 2026: Clinical trial NCT06077877 is currently active_not_recruiting participants. This clinical trial study for solid tumors is not currently accepting new participants at 6 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06077877 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06077877 was last updated 4 weeks ago (February 2, 2026). HelloStudys verifies this status automatically.